In our experience, we detected oncogenetic and likely oncogenetic variants in the ATM, BRCA1, PTEN, KMT2D, and CDH1 genes, as well as in non-metastatic PCa cases. The gene discussed is KMT2D; the disease is posterior cortical atrophy.